AcrySof™ IQ PanOptix™ UV IOL TFAT00 (REF TFAT00.200)Recalls & reported problems
Alcon Laboratories, Inc. · The AcrySof® IQ PanOptix® UV Absorbing Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant
All models of AcrySof IQ PanOptix UV IOL (28)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00380652429719), received between Aug 18, 2022 and Sep 27, 2023 — classified as 5 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
Patient problems
- Blurred Vision4
- Halo3
- Visual Disturbances3
- Visual Impairment2
- Anxiety1
- Dry Eye(s)1
- Eye Pain1
- Inflammation1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjurySep 27, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON HEALTHCARE PROFESSIONAL REPORTED THAT, AFTER INTRAOCULAR LENS IMPLANTATION SURGERY, THE PATIENT EXPERIENCED SEVERE PAIN AND ANXIETY. AFTER THE SURGERY, THE PATIENT HAD SEVER PAIN AND THE NEXT DAY, THE DOCTOR EXAMINED THE PATIENT AND IDENTIFIED THAT INTRAOCULAR PRESSURE HAS INCREASED. THE PHYSICIAN THEN INSERTED THAT NEEDLES IN THE PATIENT'S EYE TO DRAIN THE FLUID TO REDUCE THE INTRAOCULAR PRESSURE. THE PATIENT STILL HAD SEVERE PAIN, BLURRED VISION AND VISION IMPAIRMENT. THE PHYSICIAN THEN PRESCRIBED A SERIES OF ANTIBIOTIC, STEROIDS AND LUBRICANTS TO REDUCE THE PATIENT'S PAIN. THE PHYSICIAN THEN SUGGESTED THE PATIENT TO TAKE A SECOND OPINION. THE SECOND PHYSICIAN SUGGESTED THAT THE PATIENT MIGHT BE ONE OF THE 3 PERCENT OF THE PEOPLE WHOSE EYES DID NOT ADAPT TO THE LENS. HENCE THE LENS WAS EXPLANTED AND REPLACED WITH ANOTHER LENS IN A SECONDARY PROCEDURE BY THE SECOND PHYSICIAN. ADDITIONAL INFORMATION WAS RECEIVED STATING THAT THE PATIENT WAS ALSO HAVING SOME FLASHES, FLOATERS AND HE WAS HAVING SOME FLUCTUATING VISION AND DESCRIBED SYMPTOMS CONSISTENT WITH DRY EYE SYNDROME WHICH WAS POSSIBLY AGGRAVATED AS A SIDE EFFECT OF SOME POST OPERATIVE MEDICATION. THE PATIENT ALSO HAD CON
Patient problems: Anxiety; Blurred Vision; Dry Eye(s); Eye Pain; Inflammation; Intraocular Pressure Increased; Visual Disturbances; Visual Impairment; Vitreous Floaters
MAUDE report 17823674 ↗InjuryJan 27, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION RECEIVED AND STATED THAT, AFTER A MONTH OF SURGERY THE PATIENT STARTED HAVING THE SYMPTOMS. IT WAS ALSO STATED THAT PATIENT HAD REDNESS, ITCH, HALOS AND CANT SEE BLURRED EVERYTHING. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS ASSOCIATED WITH THE 1 OF 2.
Patient problems: Blurred Vision; Halo; Itching Sensation; Red Eye(s)
MAUDE report 16253624 ↗InjuryNov 25, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED STARBURST, AND HALOS AROUND LIGHTS. CONSUMER'S DOCTOR DID A LENS EXCHANGE IN BOTH EYES WITH THE COMPANY LENS. DOCTOR DID DO A LASER TREATMENT TO TRY TO HELP BUT IT MADE IT WORSE BOTH EYES. CONSUMER CAN'T DRIVE AT NIGHT BECAUSE OF THE ONCOMING LIGHTS AND ALL THE STARBURSTS AND HALOS, EVERYTHING IS DISTORTED. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS ASSOCIATED WITH THE LEFT EYE. ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED THAT SYMPTOMS STARTED IMMEDIATELY AFTER SURGERY. HAS SEEN RETINAL SPECIALIST AND FINDINGS WERE NORMAL. USING SPECIAL SUN GLASSES TO FUNCTION INDOORS. HAS LEFT HIS JOB BECAUSE OF DEBILITATING GLARE AND IMPACT ON DAILY LIVING ACTIVITIES. HAS SEEN DIFFERENT SECOND OPINION SURGEONS. HAS BEEN ON VUITY DROPS WITH NO IMPROVEMENT OVER TIME. DOES NOT RECOMMEND IOL EXCHANGE.
Patient problems: Blurred Vision; Halo; Visual Disturbances
MAUDE report 15864715 ↗InjuryNov 25, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED STARBURST, AND HALOS AROUND LIGHTS. CONSUMER'S DOCTOR DID A LENS EXCHANGE IN BOTH EYES WITH THE COMPANY LENS. DOCTOR DID DO A LASER TREATMENT TO TRY TO HELP BUT IT MADE IT WORSE BOTH EYES. CONSUMER CAN'T DRIVE AT NIGHT BECAUSE OF THE ONCOMING LIGHTS AND ALL THE STARBURSTS AND HALOS, EVERYTHING IS DISTORTED. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE. ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED THAT THE SYMPTOMS STARTED IMMEDIATELY AFTER SURGERY. HAS SEEN RETINAL SPECIALIST AND FINDINGS WERE NORMAL. USING SPECIAL SUN GLASSES TO FUNCTION INDOORS. HAS LEFT HIS JOB BECAUSE OF DEBILITATING GLARE AND IMPACT ON DAILY LIVING ACTIVITIES. HAS SEEN DIFFERENT SECOND OPINION SURGEONS. HAS BEEN ON VUITY DROPS WITH NO IMPROVEMENT OVER TIME. DOES NOT RECOMMEND IOL EXCHANGE.
Patient problems: Blurred Vision; Halo; Visual Disturbances
MAUDE report 15864655 ↗InjuryAug 18, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NURSE REPORTED FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, THE PATIENT WAS NOT ABLE TO ADAPT WITH THE LENS. THE LENS WAS EXCHANGED IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION AHS BEEN REQUESTED.
Patient problems: Visual Impairment
MAUDE report 15247356 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page